VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (VOR)
CUSIP: 929033108
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 64,806,628
- Total 13F shares
- 57,027,241
- Share change
- -3,063,359
- Total reported value
- $91,786,194
- Put/Call ratio
- 8.8%
- Price per share
- $1.62
- Number of holders
- 33
- Value change
- -$3,748,602
- Number of buys
- 15
- Number of sells
- 29
Quarterly Holders Quick Answers
What is CUSIP 929033108?
CUSIP 929033108 identifies VOR - VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 929033108:
Top shareholders of VOR - VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
61%
|
39,646,039
|
$28,446,033 | — | 31 Mar 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
1.7%
|
2,092,686
|
$5,231,715 | -$10,824,525 | 30 Jun 2025 | |
| 5AM Venture Management, LLC |
13F
|
Company |
9.8%
|
6,361,723
|
$4,564,536 | — | 31 Mar 2025 | |
| 5AM Ventures VI, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,766,634
|
$3,215,274 | — | 16 Nov 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
1,940,223
|
$1,393,080 | — | 31 Mar 2025 | |
| JOHNSON & JOHNSON |
13F
|
Company |
1.7%
|
1,074,658
|
$771,067 | — | 31 Mar 2025 | |
| Robert Ang |
3/4/5
|
PRESIDENT AND CEO, Director |
—
mixed-class rows
|
1,736,318
mixed-class rows
|
$510,338 | — | 06 May 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.1%
|
701,431
|
$503,277 | — | 31 Mar 2025 | |
| Sarissa Capital Management LP |
13F
|
Company |
0.78%
|
508,016
|
$364,501 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.75%
|
484,506
|
$347,634 | — | 31 Mar 2025 | |
| Nathan D. Jorgensen |
3/4/5
|
CHIEF FINANCIAL OFFICER |
—
mixed-class rows
|
289,403
mixed-class rows
|
$331,455 | — | 06 May 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.68%
|
438,010
|
$314,358 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.59%
|
384,293
|
$275,730 | — | 31 Mar 2025 | |
| MAI Capital Management |
13F
|
Company |
0.44%
|
288,363
|
$206,901 | — | 31 Mar 2025 | |
| Eyal C. Attar |
3/4/5
|
CHIEF MEDICAL OFFICER |
—
mixed-class rows
|
441,625
mixed-class rows
|
$179,808 | — | 13 Feb 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.3%
|
194,756
|
$139,737 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.29%
|
186,849
|
$134,064 | — | 31 Mar 2025 | |
| Tirtha Chakraborty |
3/4/5
|
Chief Sci Off & Head Tech Ops |
—
mixed-class rows
|
532,416
mixed-class rows
|
$121,752 | — | 06 May 2025 | |
| EXCHANGE TRADED CONCEPTS, LLC |
13F
|
Company |
0.23%
|
148,073
|
$106,242 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.23%
|
147,022
|
$105,488 | — | 31 Mar 2025 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.22%
|
139,600
|
$100,163 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.19%
|
122,991
|
$88,246 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
120,900
|
$86,746 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.18%
|
115,934
|
$83,183 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.15%
|
99,739
|
$71,563 | — | 31 Mar 2025 | |
| Trustees of Columbia University in the City of New York |
13F
|
Company |
0.14%
|
91,910
|
$65,991 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.13%
|
84,945
|
$60,948 | — | 31 Mar 2025 | |
| Amy Quinlan |
3/4/5
|
Vice President of Finance |
—
class O/S missing
|
50,312
|
$43,268 | — | 06 Nov 2024 | |
| Bollard Group LLC |
13F
|
Company |
0.09%
|
55,555
|
$40,000 | — | 31 Mar 2025 | |
| DGS Capital Management, LLC |
13F
|
Company |
0.13%
|
55,300
|
$39,678 | — | 31 Mar 2025 | |
| MONEY CONCEPTS CAPITAL CORP |
13F
|
Company |
0.08%
|
51,535
|
$36,976 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.07%
|
48,196
|
$34,581 | — | 31 Mar 2025 | |
| Han Wook Choi |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
366,280
mixed-class rows
|
$33,844 | — | 01 May 2025 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.07%
|
44,728
|
$32,638 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
35,441
|
$25,430 | — | 31 Mar 2025 | |
| Jain Global LLC |
13F
|
Company |
0.04%
|
24,054
|
$17,259 | — | 31 Mar 2025 | |
| GABELLI & Co INVESTMENT ADVISERS, INC. |
13F
|
Company |
0.03%
|
20,773
|
$14,905 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.03%
|
18,668
|
$13,441 | — | 31 Mar 2025 | |
| UNITED BANK |
13F
|
Company |
0.02%
|
15,300
|
$10,977 | — | 31 Mar 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.02%
|
13,425
|
$9,632 | — | 31 Mar 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.02%
|
11,859
|
$9,000 | — | 31 Mar 2025 | |
| Catalyst Funds Management Pty Ltd |
13F
|
Company |
0.02%
|
10,764
|
$7,723 | — | 31 Mar 2025 | |
| Chicago Partners Investment Group LLC |
13F
|
Company |
0.02%
|
12,731
|
$6,817 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
8,455
|
$6,071 | — | 31 Mar 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
6,959
|
$4,000 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
3,448
|
$2,474 | — | 31 Mar 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
1,985
|
$1,424 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,859
|
$1,334 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
1,017
|
$730 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
678
|
$486 | — | 31 Mar 2025 |
Institutional Holders of VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (VOR) as of Q2 2025
As of 30 Jun 2025,
VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (VOR) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,027,241 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, FMR LLC, VANGUARD GROUP INC, UBS Group AG, JOHNSON & JOHNSON, JANE STREET GROUP, LLC, Sarissa Capital Management LP, HRT FINANCIAL LP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
44
Q2 2025 holders
33
Holder diff
-11
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.